EPHX2 and cardiac hypertrophy: In angiotensin II-induced cardiac hypertrophy H9C2 cell models, the sEH inhibitor TUPS inhibits autophagy by activating the mTOR signaling pathway, reducing the expression of cardiac hypertrophy markers ANP and BNP, and alleviating cardiac hypertrophy (Zhang et al., 2019).